Swisslex vs. Legora vs. Enclava: Three Approaches to Swiss Legal Research

An honest comparison of the three platforms for Swiss legal research. Where each excels, where each falls short, and which suits whom.

Swisslex vs. Legora vs. Enclava: Three Approaches to Swiss Legal Research

Anyone working professionally with law in Switzerland knows the question: which tool? There are established providers and new ones. All promise faster, better research. But the differences lie in the architecture, not in the marketing.

This comparison is as honest as possible. We are one of the three providers, so we are biased. We try to be fair regardless. No embellishment about us, no distortion about the others. The facts are publicly available.

The Three Models

Swisslex: The Publisher

Swisslex is the most widely used legal research tool in Switzerland. Operated by Schulthess (part of the NZZ Group). On the market for over 20 years.

Strengths:

  • Breadth. Statutes, decisions, journal articles, commentaries. The largest overall package.
  • Exclusive content. Legal journals (AJP, SJZ, ZSR, and many more) and publisher commentaries are only available here. No scraper in the world can replicate published academic articles.
  • Market position. De facto standard in Swiss law firms. If you practise law, you have Swisslex. Period.
  • Reliability. Editorially curated. Statutes are reviewed by editors before they go online.

Weaknesses:

  • Search quality. Keyword search. No semantic understanding. Choose the wrong term, find nothing. Choose the right term, find too much.
  • Price. For mid-sized firms, five figures per year. Barely affordable for small firms and fiduciaries. Exact prices only on request.
  • Cantonal coverage. Federal Supreme Court decisions are complete. Cantonal case law is inconsistent. Some cantons are well covered, others barely.
  • No API. No programmatic access. No integration into custom workflows.
  • Speed. Uploading new decisions takes time. Days to weeks can pass between publication by the court and availability on Swisslex.

Legora: The AI Challenger

Legora is a Swiss legal tech startup. Funded with over CHF 4 million in 2024. Valued at over CHF 30 million. Positioned as an AI-powered alternative to the traditional databases.

Strengths:

  • AI search. Natural language queries. Instead of keywords, you can ask questions.
  • Modern interface. Fast, clean, contemporary. Feels like a modern product.
  • Funding. Well capitalised. Can invest in product development.
  • Focus on usability. Low entry barrier.

Weaknesses:

  • Source verification. Legora uses AI models for processing. As with any LLM-based system, there is a risk of hallucination. The question is: how is it ensured that every answer traces back to a real source?
  • Third-party dependency. Uses external AI models (presumably OpenAI or similar). Data flows to US servers. Problematic for firms with strict confidentiality requirements.
  • Limited data depth. Whether Legora covers all 26 cantons, all 115 courts, and the entire cantonal case law is not clearly communicated.
  • Still young. Little track record. The question is not whether the product works today, but whether it will still exist in five years.

Enclava: The Data Platform

Enclava is our product. We are biased. Here is the honest assessment regardless.

Strengths:

  • Data scope. 27,795 statutes, 2.02 million law units, 1.14 million court decisions, 115 courts, 26 cantons, FINMA (27 tables), SHAB (2.5 million entries). All from official sources.
  • Source verification. Every data point links to the official government source. No editorial modification of original texts. What the government publishes is what you see.
  • Citation graph. 1.42 million citation edges. Which decision cites which article? How has case law evolved? Neither Swisslex nor Legora can match this depth.
  • Semantic search. Embeddings across the entire corpus. Search by concepts, not just words.
  • Up-to-date daily. Nightly scraping. What was published yesterday is searchable today.
  • Price. CHF 990/month for a firm. A fraction of Swisslex.
  • Data sovereignty. Swiss hosting. No data flows to US cloud providers.

Weaknesses:

  • No publisher content. No journal articles, no commentaries, no academic papers. Those who need the SJZ or the Basler Kommentar need Swisslex. We cannot replicate this and do not attempt to.
  • No track record. We are new. That is a legitimate concern. Those who have relied on Swisslex for 20 years have good reasons not to switch.
  • Not yet a complete product. Some features (interactive citation graph, WatchTower alerts, configurable watchlists) are in development. They are not live.
  • Small team. We do not have the resources of a publisher. If something breaks, the repair takes longer.

The Honest Comparison

Criterion Swisslex Legora Enclava
Federal statutes Complete Partial Complete
Cantonal statutes (26 cantons) Partial Unclear Complete
Federal Supreme Court decisions Complete Complete Complete
Cantonal decisions (115 courts) Partial Unclear 1.14 million
Journals/commentaries Yes (exclusive) No No
Semantic search No Yes Yes
Citation graph Limited No 1.42 million edges
FINMA coverage Partial No 27 tables
SHAB data No No 2.5 million entries
Daily currency No (days-weeks lag) Unclear Yes (nightly)
Data sovereignty Switzerland Unclear (external LLMs) Switzerland
API access No Unclear Planned
Price (firm) CHF 5,000-30,000+/year On request CHF 990/month
On market since 2000+ 2024 2026

Who Needs What?

Large firm (50+ lawyers): Swisslex remains indispensable for publisher content. Enclava as a complement for cantonal coverage, citation analysis, and FINMA research.

Mid-sized firm (10-50 lawyers): This is where it gets interesting. If the practice does not rely heavily on publisher commentaries (commercial law, compliance, tax law), Enclava can be the primary research platform. Swisslex as a complement for cases where a commentary is needed.

Fiduciary/advisory: Swisslex is often too expensive and too legal. Legora is an option if the AI search convinces. Enclava is built for this market: broad coverage, fair prices, no legal expertise required.

FINMA-supervised institutions: None of the three platforms previously had a FINMA focus. Enclava is the only one with systematic FINMA coverage (27 tables, circulars, enforcement).

Solo practitioner or small firm: Budget is the bottleneck. Swisslex is too expensive. Legora is an option. Enclava at CHF 990/month is at the limit. For solo practitioners, we will offer a smaller package.

What We Can Learn from Each Other

Swisslex has something that neither Legora nor we have: two decades of trust. That does not come from marketing. It comes from the product working every day for twenty years. For lawyers standing in court who must rely on their source, track record is non-negotiable.

Legora has something Swisslex lacks: a modern user interface and the courage to position AI as a core feature. That lowers the entry barrier for users who are not lawyers.

We have something both lack: depth of data. 1.14 million decisions, 115 courts, 1.42 million citation edges, 27 FINMA tables. Data that comes directly from the source, without editorial filter, without lag.

The Swiss legal tech market is large enough for all three. The question is not who wins. The question is who builds the right tool for which user.

Our Recommendation

Try all three. Seriously.

If you have Swisslex and are satisfied: stay with it. Test Enclava as a complement for the areas Swisslex does not cover.

If you do not have Swisslex and do not need publisher content: look at Enclava. The data depth is real. The price is fair.

If you primarily want an AI-powered search and data sovereignty is not a critical concern: look at Legora.

The best platform is the one that improves your specific workflow. Not the one with the nicest website.


This article is for informational purposes and does not constitute legal advice. Mont Virtua is the provider of the Enclava platform and is therefore biased in this comparison. All statements about third-party providers are based on publicly available information (as of March 2026).

Back to Insights

Related articles